CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | Latour Wouter Director | Option exercise | +100,000 | $1.70 | $170K | 100,000 |
| 2021-05-07 | Latour Wouter Director | Sale | −100,000 | $7.13 | $713K | 0 |
| 2021-05-07 | Latour Wouter Director | Option exercise · Stock Option (right to buy) | −100,000 | 700,000 | ||
| 2021-05-06 | Latour Wouter Director | Option exercise | +100,000 | $1.70 | $170K | 100,000 |
| 2021-05-06 | Latour Wouter Director | Sale | −100,000 | $6.54 | $654K | 0 |
| 2021-05-06 | Latour Wouter Director | Option exercise · Stock Option (right to buy) | −100,000 | 800,000 | ||
| 2021-03-04 | Latour Wouter Director | Option exercise | +150,000 | $0.77 | $116K | 150,000 |
| 2021-03-04 | Latour Wouter Director | Sale | −150,000 | $6.04 | $906K | 0 |
| 2021-03-04 | Latour Wouter Director | Option exercise · Stock Option (right to buy) | −150,000 | 213,261 | ||
| 2020-11-23 | Latour Wouter Director | Sale | −333,334 | $6.32 | $2.1M | 0 |
| 2020-08-12 | Latour Wouter Director | Option exercise | +166,667 | $0.30 | $50K | 333,334 |
| 2020-08-12 | Latour Wouter Director | Option exercise · Common Stock Purchase Warrant | −166,667 | $0.30 | $50K | 0 |
| 2020-06-08 | Latour Wouter President and Chief Executive | Grant or award · Stock Option (right to buy) | +900,000 | 900,000 | ||
| 2019-09-30 | Latour Wouter President and Chief Executive | Purchase | +166,667 | $0.30 | $50K | 166,667 |
| 2019-09-30 | Latour Wouter President and Chief Executive | Purchase · Common Stock Purchase Warrant | +166,667 | $0.30 | $50K | 166,667 |
| 2019-05-12 | Latour Wouter President and Chief Executive | Grant or award · Stock Option (right to buy) | +363,261 | 363,261 | ||
| 2018-05-25 | Latour Wouter President and Chief Executive | Grant or award · Stock Option (right to buy) | +110,700 | 110,700 | ||
| 2018-02-13 | Latour Wouter President and Chief Executive | Grant or award · Stock Option (right to buy) | +6,536 | 6,536 | ||
| 2018-02-13 | Latour Wouter President and Chief Executive | Grant or award · Stock Option (right to buy) | +9,442 | 9,442 | ||
| 2018-02-13 | Latour Wouter President and Chief Executive | Grant or award · Stock Option (right to buy) | +13,256 | 13,256 |
Page 1 of 2 · 24 trades